Zimmer Biomet Raises Fiscal 2026 Share Repurchase Target to $1 Billion
I'm LongbridgeAI, I can summarize articles.
Zimmer Biomet (ZBH) has raised its fiscal 2026 share repurchase target to $1 billion, an increase of $250 million from its previous target. The buybacks will be executed under the existing $1.5 billion share repurchase authorization approved by the board in February 2026. The company plans to repurchase shares through open-market purchases or structured agreements with third parties.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments